PIK3CA and neoplasm: Our data presented here demonstrated that PIK3CA (E545K) mutation was significantly associated with tumor recurrence in stage III, besides, E545K also played as an independent prognostic gene biomarker for adverse outcomes in stage III colon cancer alone.